digital currency scope and challenges Reviews

ExxonMobil: By 2030, we plan to invest about 140 billion US dollars in major projects and Permian basin development plans.China Overseas Development: The annual interest of "23 Zhonghai 04" will be paid on December 12th. On December 10th, China Overseas Development (00688.HK) announced that China Overseas Enterprise Development Group Co., Ltd., a wholly-owned subsidiary of the company, will pay the annual interest of "23 Zhonghai 04" on December 12th, totaling 96 million yuan. The total amount of bonds issued in this issue is 3 billion yuan, and the issuance period is 5 years. The coupon rate of bonds in this issue is 3.20%.CEO of audi ag: I hope to keep pace with BYD in China. audi ag is in the stage of strategic stability and will enter the growth stage of new energy vehicles from 2026. Audi ag hopes to maintain its leading position in the China market and keep pace with BYD. On December 10th, 2024, Oliver Blume, CEO of German audi ag, made the above remarks in a speech at Tongji University. (Caixin. com)

Survey by Monetary Authority of Singapore: Economists have lowered Singapore's non-oil domestic export growth forecast from 3.0% to 1.0% in 2024.Tik Tok's concept change has increased the daily limit of the provincial broadcasting group, Tik Tok's concept change has increased, and the daily limit of the provincial broadcasting group, Aohai Technology, Gravity Media and 3D Communication has increased, and Tianlong Group, Haitian Ruisheng and Silk Road Vision have also increased.Starbucks China responded to the newly created position of Chief Growth Officer: to promote the sustainable development of Starbucks brand in China. Recently, some media reported that the management of Starbucks China continued to adjust and hired CGO to manage the growth from digital marketing companies. In response to the above information, Sina Technology verified Starbucks, and the official response said: China is Starbucks' largest international market and an important engine for the company's future growth. In November, Starbucks China established the Chief Growth Officer (CGO) organization and appointed Tony Yang as the company's Chief Growth Officer (CGO). The establishment of CGO organization will continue to strengthen Starbucks' coffee leadership, accelerate the product innovation with coffee as the core, better refresh customers' Starbucks experience at various contacts through integrated marketing strategies, and promote the sustainable development of Starbucks brand in China. At present, Starbucks has more than 7,600 stores in China, reaching a new development milestone covering 1,000 county-level markets. (Sina Technology)

There is a wave of "restriction on purchases" in the public offering market. The announcement of Huitianfu Fund on December 11th shows that since December 12th, Huitianfu Enhanced Income Bond A has suspended large-scale subscription, large-scale conversion and large-scale fixed investment business, and the amount of single or multiple cumulative subscriptions, conversion and fixed investment in a single fund account per day should not exceed 10 million yuan (inclusive). Recently, the reporter found that there is a "restricted purchase tide" in the public offering market. Whether it is active equity funds, bond funds or QDII funds, many outstanding products have recently announced the suspension of large-scale subscription, and even QDII products have directly "closed the market" and suspended all buying operations. (CSI)German Foreign Minister: We have seen hope in Syria.Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.